Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis

被引:15
作者
Durkin, M
Kohler, S
Schnizlein-Bick, C
LeMonte, A
Connolly, P
Goldberg, J
Garringer, T
Wheat, LJ
机构
[1] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] Histoplasmosis Reference Lab, Indianapolis, IN USA
[3] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA
关键词
D O I
10.1086/320720
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reactivation may be a mechanism for the development of histoplasmosis in AIDS. In this study, histoplasmosis was reactivated by the depletion of CD4 and CD8 lymphocytes in mice. CD4 and/or CD8 depletion beginning 1 month after intratracheal infection and continuing for 2 months caused reactivation with a 2.1 log/g increase in the lungs and a 1.5 log increase in the spleen of B6C3F1 mice. Because control animals showed persistent infection, a subsequent experiment sought to determine the long-term outcome in competent mice. Twelve of 32 immunocompetent mice died at weeks 26-52 of infection, and 4 survivors appeared to be clinically ill; all ill mice had high fungus burdens, whereas cultures were sterile in the healthy mice. Eight of the surviving healthy-appearing mice underwent autopsy 2 years after infection, and cultures were sterile. Thus, 16 of 32 immunocompetent mice exhibited progressive infection. CD4 and/or CD8 depletion exacerbated infection, but a chronic progressive and ultimately fatal infection occurred in half the immunocompetent mice.
引用
收藏
页码:1822 / 1824
页数:3
相关论文
共 8 条
[1]   Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis [J].
Cano, LE ;
Kashino, SS ;
Arruda, C ;
André, D ;
Xidieh, CF ;
Singer-Vermes, LM ;
Vaz, CAC ;
Burger, E ;
Calich, VLG .
INFECTION AND IMMUNITY, 1998, 66 (02) :800-806
[2]   Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice [J].
Connolly, P ;
Wheat, LJ ;
Schnizlein-Bick, C ;
Durkin, M ;
Kohler, S ;
Smedema, M ;
Goldberg, J ;
Brizendine, E ;
Loebenberg, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2604-2608
[3]   RANK TRANSFORMATIONS AS A BRIDGE BETWEEN PARAMETRIC AND NONPARAMETRIC STATISTICS [J].
CONOVER, WJ ;
IMAN, RL .
AMERICAN STATISTICIAN, 1981, 35 (03) :124-129
[4]   DISSEMINATED HISTOPLASMOSIS IN IMMUNOLOGICALLY SUPPRESSED PATIENTS - OCCURRENCE IN A NON-ENDEMIC AREA [J].
DAVIES, SF ;
KHAN, M ;
SAROSI, GA .
AMERICAN JOURNAL OF MEDICINE, 1978, 64 (01) :94-100
[5]   LOCAL IMMUNITY IN LUNG-ASSOCIATED LYMPH-NODES IN A MURINE MODEL OF PULMONARY HISTOPLASMOSIS [J].
FOJTASEK, MF ;
SHERMAN, MR ;
GARRINGER, T ;
BLAIR, R ;
WHEAT, LJ ;
SCHNIZLEINBICK, CT .
INFECTION AND IMMUNITY, 1993, 61 (11) :4607-4614
[6]   TYPING OF HISTOPLASMA-CAPSULATUM BY RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN A NUCLEAR GENE [J].
KEATH, EJ ;
KOBAYASHI, GS ;
MEDOFF, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) :2104-2107
[7]   Transmission of Histoplasma capsulatum by organ transplantation [J].
Limaye, AP ;
Connolly, PA ;
Sagar, M ;
Fritsche, TR ;
Cookson, BT ;
Wheat, LJ ;
Stamm, WE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) :1163-1166
[8]   THE HEALED PRIMARY COMPLEX IN HISTOPLASMOSIS [J].
STRAUB, M ;
SCHWARZ, J .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1955, 25 (07) :727-741